DigiTx Partners

Mightier is a gaming platform designed to assist children in regulating their emotions through scientifically-backed methods. Founded in 2016 and based in Boston, Massachusetts, the platform features bioresponsive video games developed in collaboration with Boston Children's Hospital and Harvard Medical School. The games utilize a biofeedback heart rate monitor that adjusts the difficulty level based on the player's emotional state, helping children learn to manage their feelings in real-time. By engaging with these interactive experiences, children with behavioral and emotional challenges can discover their emotional strengths and develop skills to harness their emotions in everyday situations.

Rune Labs, Inc. is a San Francisco-based company that has developed a software-as-a-service platform for neuromodulation therapies. Founded in 2018, the platform integrates with existing and emerging neuromodulation systems to manage and analyze complex therapy data. It assists pharmaceutical and med-tech companies in utilizing brain imaging and electrophysiology data generated during clinical studies and patient care. By providing a secure, cloud-based infrastructure, Rune Labs enables its partners to effectively organize and analyze large volumes of brain data, facilitating the development of precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The platform enhances the performance and scalability of therapy algorithms, ultimately aiding in the identification of potential responders for clinical trials and the advancement of adaptive therapy applications.

Cleerly is a healthcare company focused on improving the prevention of heart attacks through innovative digital care pathways. It aims to establish a new standard for coronary artery disease by combining advanced clinical science with cutting-edge artificial intelligence. Cleerly's platform offers a non-invasive approach that quantifies and characterizes plaque buildup in coronary arteries, enhancing the understanding of cardiovascular health. By providing actionable clinical insights, the company enables healthcare providers to better identify at-risk patients and implement early treatment strategies. Ultimately, Cleerly's data-driven solutions aspire to deliver significant value to the healthcare system while improving heart health outcomes for individuals susceptible to heart attacks.

Nēsos develops and commercializes electrical field treatments for neurological disorders. It is critically supported by expert clinical and scientific collaborators from leading academic institutions, including Stanford, Vall d'Hebron, Harvard, Mount Sinai, Feinstein Institute, University Of California, San Diego (UCSD), and the University Of California, San Francisco (UCSF). It was co-founded by Konstantinos Alataris and other neuroscientists.

Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.

Rune Labs, Inc. is a San Francisco-based company that has developed a software-as-a-service platform for neuromodulation therapies. Founded in 2018, the platform integrates with existing and emerging neuromodulation systems to manage and analyze complex therapy data. It assists pharmaceutical and med-tech companies in utilizing brain imaging and electrophysiology data generated during clinical studies and patient care. By providing a secure, cloud-based infrastructure, Rune Labs enables its partners to effectively organize and analyze large volumes of brain data, facilitating the development of precision therapies for conditions such as Parkinson's disease, epilepsy, depression, and obsessive-compulsive disorder. The platform enhances the performance and scalability of therapy algorithms, ultimately aiding in the identification of potential responders for clinical trials and the advancement of adaptive therapy applications.

G-Tech Inc. is a healthcare technology company based in Mountain View, California, founded in 2008. The company specializes in developing a wireless and wearable disposable electrode patch designed to assist patients with functional gastrointestinal disorders. This innovative GutCheck patch measures the electrical activity of the stomach, small intestine, and colon, providing valuable data that is transmitted to a smartphone and subsequently to a cloud server. The technology aims to address the limitations of traditional diagnostic methods, such as colonoscopies and CT scans, which often fail to identify functional disorders in patients experiencing symptoms like abdominal pain, constipation, diarrhea, or bloating. Additionally, G-Tech Inc. offers an application for physicians to analyze the collected data, enhancing their ability to diagnose and tailor treatments for gastrointestinal motility issues.

nQ Medical Inc., founded in 2016 and based in Cambridge, Massachusetts, specializes in developing innovative solutions for the detection and management of neurocognitive and neuromotor disorders. The company has created neuroQWERTY, an artificial intelligence tool that passively collects data through everyday use of electronic devices, enabling 24/7 monitoring of disease progression and therapeutic effectiveness. This frictionless and non-invasive platform captures subtle changes in user interactions, such as typing and touchscreen behavior, which are often overlooked by traditional clinical assessments. With proven capabilities demonstrated in extensive clinical trials, nQ Medical aims to facilitate early detection of disorders like Alzheimer's, Parkinson's, and multiple sclerosis, while offering a cost-effective alternative to current diagnostic methods. By providing patients and clinicians with a reliable means to track disease status and treatment impact, nQ Medical is positioned to enhance the management of neurological conditions significantly.

Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.

Embr Labs Inc. is a technology company based in Somerville, Massachusetts, that specializes in thermal comfort solutions. Founded by three MIT scientists in 2014, the company develops wearable devices designed to help individuals control their body temperature. Its flagship product, the Embr Wave, is an intelligent bracelet that employs advanced algorithms to create temperature sensations in waves, effectively engaging the body's natural response to temperature changes. By utilizing patented technology, Embr Labs aims to provide a safe and non-invasive means for users to experience improved comfort, whether at home or on the go. The company has garnered support from notable investors, including Bose Ventures and Intel Capital, reflecting its innovative approach to wellness through technology.

Neosensory, Inc. is a company that specializes in developing wearable devices aimed at enhancing sensory perception for individuals. Founded in 2015 and based in San Mateo, California, Neosensory offers products such as Buzz, which utilizes vision-to-touch sensory substitution technology to assist blind individuals. The company focuses on transmitting various data streams to the brain through the sense of touch, leveraging the skin's potential for information delivery. Their innovative approach includes building hearing assistive technology that allows users to perceive sound through vibrations on the skin. Neosensory also provides a companion application for its products, enhancing the user experience and accessibility of information.

Savonix, Inc. is a San Francisco-based company that specializes in developing a digital neuro-cognitive assessment and brain health platform. Founded in 2014, its flagship product, Savonix Mobile, allows users to perform clinically recognized cognitive assessments on mobile devices. This platform provides accessible tests covering various cognitive domains, such as memory and implicit learning, which are guided by virtual clinicians. Savonix's assessments are designed to help healthcare providers, researchers, and insurers understand cognitive risks, including those related to dementia, and to inform treatment planning and diagnosis. The company has established strategic partnerships with notable institutions, including New York University and several biotech firms. Unique features of the platform include a 3D gaming component that generates additional cognitive insights without requiring separate tests, enhancing the understanding of cognitive function in aging populations. Savonix aims to deliver an affordable, scalable, and actionable solution for monitoring cognitive health, making it a leader in the field of digital cognitive assessment.

Savonix, Inc. is a San Francisco-based company that specializes in developing a digital neuro-cognitive assessment and brain health platform. Founded in 2014, its flagship product, Savonix Mobile, allows users to perform clinically recognized cognitive assessments on mobile devices. This platform provides accessible tests covering various cognitive domains, such as memory and implicit learning, which are guided by virtual clinicians. Savonix's assessments are designed to help healthcare providers, researchers, and insurers understand cognitive risks, including those related to dementia, and to inform treatment planning and diagnosis. The company has established strategic partnerships with notable institutions, including New York University and several biotech firms. Unique features of the platform include a 3D gaming component that generates additional cognitive insights without requiring separate tests, enhancing the understanding of cognitive function in aging populations. Savonix aims to deliver an affordable, scalable, and actionable solution for monitoring cognitive health, making it a leader in the field of digital cognitive assessment.

LifeLink is the conversational engagement platform for healthcare. We work with some of the largest healthcare systems and pharma companies in the country to reach their patients on mobile and messaging, with personalized, natural, and contextual conversations. LifeLink chatbots automate thousands of high-value patient touchpoints before, during, and after healthcare visits, resulting in improved operational efficiency, increased customer satisfaction, and superior brand loyalty.

Eko harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sound to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko was established in 2013 and is based in Berkeley, California.

Tissue Analytics, Inc. is a company that develops a mobile application designed to facilitate the measurement and analysis of chronic wounds, burns, and skin conditions. This innovative solution allows home health agencies, nursing homes, and medical practices to send patient photographs and perform wound analysis. The application automatically generates formatted patient reports and enables tracking of patient progress regarding their treatments. Additionally, it provides tools for remote patient evaluation and management, utilizing skin and wound analysis algorithms to measure, segment, and classify images. The platform ensures secure transport of protected health information from the patient's bedside to the provider's desktop. Established in 2014 and based in Baltimore, Maryland, Tissue Analytics operates as a subsidiary of Net Health Systems, Inc. The company has formed a strategic alliance with MolecuLight Inc. to further enhance its offerings.

Siris Medical, Inc. provides artificial intelligence treatment decision support system in radiation therapy for cancer patients. Its product includes InsightRT Software Suite, which enables to manage the patients; QuickMatch, and PlanMD that can be used independently or together. The company was founded in 2013 and is based in Redwood City, California.

Savonix, Inc. is a San Francisco-based company that specializes in developing a digital neuro-cognitive assessment and brain health platform. Founded in 2014, its flagship product, Savonix Mobile, allows users to perform clinically recognized cognitive assessments on mobile devices. This platform provides accessible tests covering various cognitive domains, such as memory and implicit learning, which are guided by virtual clinicians. Savonix's assessments are designed to help healthcare providers, researchers, and insurers understand cognitive risks, including those related to dementia, and to inform treatment planning and diagnosis. The company has established strategic partnerships with notable institutions, including New York University and several biotech firms. Unique features of the platform include a 3D gaming component that generates additional cognitive insights without requiring separate tests, enhancing the understanding of cognitive function in aging populations. Savonix aims to deliver an affordable, scalable, and actionable solution for monitoring cognitive health, making it a leader in the field of digital cognitive assessment.

Juji's mission is to democratize the power of artificial intelligence to help move humanity forward. Currently, Juji provides a cloud based software as a service platform for creating Do-It-Yourself AI chatbots. Juji platform integrates the latest advances in artificial intelligence, such as deep learning, natural language processing and machine learning, and makes them usable for non-technical business professionals as part of their daily workflow.

FITNESS & WELLNESS TRACKING MODULES All our platforms offer Bluetooth Smart (Low Energy) wireless, USB charging and data connectivity, Flash memory, and a choice of processing power & of sensors. -Now: 16 bit MCU and gyroscopes, accelerometers, compass, pressure & temperature sensors. -In Q2 2014: 32 bit MCU and, in addition to the above sensors, optional ones such as heart rate, oxygen, humidity, UV, muscle strain, etc.